Html code here! Replace this with any non empty raw html code and that's it.

Scientists may have found the key to GLP-1-based weight loss β€” without the worst side effects

Date:

Share this article:

Del denne artikel:

New brain research suggests that GLP-1 medications may offer weight loss without the most uncomfortable side effects.

Many people who use modern weight-loss medication know the mixed feeling all too well: the appetite fades, the numbers on the scale begin to change, yet nausea and discomfort often make the experience far less motivating than expected.

For anyone who has wondered why these medications feel so demanding on the body, new brain research may be starting to offer an answer.

Understanding the brain’s hidden reactions

At this year’s Neuroscience 2025 conference, several U.S. research teams presented findings that shed new light on how GLP-1 drugs work deep inside the brain.

Scientists from the University of Washington, the University of Michigan, the University of Virginia and the University at Buffalo investigated how the medications influence hunger, reward-driven eating, nausea and even thirst.

Also read: New drug candidate compared to existing GLP-1 treatments

Their work suggests that the effects of drugs like semaglutide and tirzepatide are shaped by multiple neural pathways working at the same time.

What new experiments reveal

One study showed that combining low-dose tirzepatide with the hormone oxytocin produced a meaningful weight reduction in rats without signs of stomach discomfort.

Other research focused on brain regions tied to nausea, including the area postrema, which appears to be involved in both appetite suppression and unpleasant sensations.

Additional experiments mapped a neural circuit in the amygdala linked to reduced cravings for highly rewarding foods, offering clues to why emotional eating changes on these medications.

Also read: Kiwifruit might be the answer to your digestion problems

What this could mean for future treatment

If scientists succeed in separating appetite-regulating pathways from those that trigger nausea, next-generation GLP-1 therapies could become far more comfortable to use.

Specialists believe this may eventually lead to treatments that support weight loss while maintaining normal hydration signals and reducing the likelihood of stopping medication early.

The article is based on information from Society for Neuroscience and ScienceDaily

Also read: Research explores link between hair colour and wound recovery

Also read: Long-term study shows lasting health effects of eating disorders

Other articles

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.

New analysis: Six out of ten women may be overweight in 2050

Developments in women’s health point in a worrying direction. Cardiovascular diseases in particular may become more prevalent in the future.

Studies suggest possible link between tattoos and cancer

Several scientific studies point to a possible connection between tattoo ink and an increased risk of certain types...

Price war in weight-loss market: Novo Nordisk slashes prices

Competition in the U.S. weight-loss drug market is intensifying. Novo Nordisk is now responding with a significant price cut.

Results from 159,000 participants suggest this diet may reduce the risk of cognitive decline

New research indicates that healthy choices in midlife may reduce the risk of cognitive decline later on.